M. Blanc

发表

R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study

T. Molina, G. Salles, H. Tilly, 2009 .

Long term outcome of patients with hairy cell leukemia treated with pentostatin

G. Salles, B. Coiffier, M. Blanc, 1999, Cancer.

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

J. Blay, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

C. Sebban, M. Henry-Amar, E. Noordijk, 2005 .

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon α-2b for the treatment of chronic myelogenous leukemia patients in chronic phase

E. Solary, C. Chastang, D. Coso, 2002, Leukemia.

Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma

X. Leleu, J. Jamart, C. Mathiot, 2004, Annals of Hematology.

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

S. Chevret, E. Wattel, P. Fenaux, 2012, Haematologica.

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

T. Molina, B. Coiffier, P. Feugier, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.

P. Fenaux, M. Sébert, L. Adès, 2011, Leukemia research.

Lenalidomide in lower‐risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis‐stimulating agents

E. Wattel, P. Fenaux, N. Vey, 2012, British journal of haematology.

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study

G. Salles, O. Casasnovas, H. Tilly, 2011, Haematologica.

Systematic donor blood qualification by flow cytometry would have been able to avoid CLL‐type MBL transmission after unrelated hematopoietic stem cell transplantation

P. Rohrlich, F. Garnache-Ottou, E. Deconinck, 2012, European journal of haematology.

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, É. Lepage, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy

F. Berger, É. Lepage, P. Brice, 2001, Cancer.

Risk of AML Evolution In Lower Risk MDS with Del 5q Treated with or without Lenalidomide. A Report by the Groupe Francophone Des Myelodysplasies (GFM)

S. Chevret, P. Fenaux, M. Sébert, 2010 .

Treatment of Lower Risk MDS with Del 5q with Lenalidomide (LEN): Results of the French ATU Program.

E. Wattel, P. Fenaux, M. Sébert, 2009 .

Interferon Alpha and Cytosine Arabinoside in the Treatment of Chronic Myelogenous Leukemia

R. Bouabdallah, F. Bauters, N. Ifrah, 1998 .

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.

P. Gaulard, J. Diebold, P. Biron, 1996, The American journal of surgical pathology.

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2003, Blood.

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

F. Jardin, P. Gaulard, B. Coiffier, 2011, The Lancet. Oncology.

standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Intensive conventional chemotherapy (ACVBP regimen) compared with

T. Molina, B. Coiffier, H. Tilly, 2009 .

Intensive chemotherapy in aggressive lymphomas: updated results of LNH-80 protocol and prognostic factors affecting response and survival.

F. Berger, B. Coiffier, C. Sebban, 1987, Blood.

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

B. Coiffier, B. Grosbois, C. Sebban, 2003, Leukemia.

Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study

T. Conroy, T. Petrella, B. Quesnel, 2002 .

elderly multiple myeloma patients ineligible for high-dose therapy Dexamethasone-based regimens versus melphalan-prednisone for

J. Rossi, R. Bataille, I. Yakoub-Agha, 2011 .

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Augustin Ferrant, Chantal Doyen, J. Rossi, 2006 .

Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.

B. Coiffier, C. Dumontet, P. Felman, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study.

E. Wattel, X. Thomas, E. Archimbaud, 1999, Leukemia & lymphoma.

Treatment of chronic myelogenous leukemia in blast crisis and in accelerated phase with high- or intermediate-dose cytosine arabinoside and amsacrine.

A. Delmer, F. Bauduer, R. Zittoun, 1993, Leukemia & lymphoma.

Groupe d'Etude des Lymphomes de l'Adulte (GELA) patients with advanced-stage Hodgkin lymphoma: a study by the Long-term results and competing risk analysis of the H89 trial in

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2013 .

Phase II study of PEG-Intron in combination with chemotherapy for the treatment of first line patients with follicular lymphoma who need to be treated.

P. Feugier, C. Haioun, F. Bauduer, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2006, Blood.

Treatment of acute schizophrenia with paliperidone ER: Predictors for treatment response and benzodiazepine use

A. Siracusano, S. Heres, V. Mačiulis, 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .

Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes.

F. Berger, P. Miossec, J. Jeanneret, 1999, Arthritis and rheumatism.

Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2006 .

Lenalidomide (LEN) In Lower-Risk Myelodysplastic Syndromes (MDS) with Karyotypes Other Than Deletion 5q and Refractory to Erythropoiesis-Stimulating Agents (ESAs)

E. Wattel, P. Fenaux, N. Vey, 2010 .